MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Validation of the International Parkinson and Movement Disorder Society – Non-Motor Symptoms – Questionnaire (MDS-NMS-Q)

    D. Weintraub, KR. Chaudhuri, A. Schrag, P. Martinez-Martin, A. Rizos, E. Mamikonyan, J. Gallagher, J. Staunton, M. Pereira Fernandes, C. Rodriguez Blazquez (Philadelphia, USA)

    Objective: To validate the self-completed version of the International Movement Disorder Society – Non-Motor Rating Scale (MDS-NMS)1, named the MDS-NMS – Questionnaire (MDS-NMS-Q). Background: The…
  • 2024 International Congress

    Exploring Supervised and Real-World Mobility in People with Parkinson’s Disease with and without Nocturnal Hypokinesia

    E. Bianchini, D. Rinaldi, S. Galli, M. Alborghetti, L. de Carolis, P. Petit, P. Pacilio, T. Milane, C. Hansen, FE. Pontieri, N. Vuillerme (Rome, Italy)

    Objective: To evaluate supervised and real-world mobility in people with Parkinson’s disease (PwPD) with and without nocturnal hypokinesia (NH). Background: Mobility impairment and NH are…
  • 2024 International Congress

    Gastrointestinal Dysbiosis and Clinical Outcomes in Parkinson’s Disease

    K. Julio, A. Vakhtin, H. Lin, A. Birg, N. Hoffman, S. Nitschke, N. Shaff, E. Erhardt, A. Mayer, D. Sugar, G. Suarez Cedeno, A. Deligtisch, S. Pirio Richardson, S. Ryman (Albuquerque, USA)

    Objective: To evaluate whether patients with PD exhibit 1) a bloom in sulfate-reducing bacteria based on the detection of hydrogen-sulfide (H2S) during lactulose breath testing…
  • 2024 International Congress

    Behavioral health characteristics of pre-surgical Focused Ultrasound and Deep Brain Stimulation candidates

    D. Kim, S. O'Neill, S. Murthy, A. Waters, C. Palmese (Bronx, USA)

    Objective: To characterize psychological traits in patients who pursue focused ultrasound (FUS) versus deep brain stimulation (DBS) for tremor management Background: Psychosocial characteristics can determine…
  • 2024 International Congress

    Plasma NFL predicting fatigue conversion in early Parkinson’s disease

    NN. Che (Chengdu, China)

    Objective: we explore if there was an association between plasma NFL and different fatigue subtypes and whether baseline plasma NFL level can predict fatigue subtype…
  • 2024 International Congress

    The effect of Diabetes Mellitus and Cardiovascular disease on Parkinson’s disease

    T. Abali, SN. Kibrit, Z. özdamar, İ. Köker, AV. Karacan, MK. Yekedüz, R. Yilmaz, FT. Eminoglu, MC. Akbostancı (Ankara, Turkey)

    Objective: To understand the impact of the comorbidities; namely Type 2 Diabetes Mellitus (DM) and/or cardiovascular disease (CVD) on the clinical features of Parkinson’s disease…
  • 2024 International Congress

    Clinical Predictors of Impulse Control Disorders in Parkinson’s Disease

    T. Breddy, P. Macdonald, K. van Hedger, H. Ganjavi (London, Canada)

    Objective: To investigate whether anxiety, depression, and sleep impairment relate to development of impulse control disorders (ICD) in patients with early-stage Parkinson’s disease (PD). Background:…
  • 2024 International Congress

    Interim Report of Quality of Life Outcomes After Deep Brain Stimulation for Parkinson’s Disease from a Large Global Real-World Study

    A. Gharabaghi, L. Lopez, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Tuebingen, Germany)

    Objective: To summarize quality of life outcomes after 2 years of deep brain stimulation (DBS) for Parkinson’s disease (PD). Background: DBS improves motor fluctuations associated…
  • 2024 International Congress

    Age of Onset and Non-Motor Symptoms in Early Parkinson’s Disease: A Data-Analysis Study Based on the Fox Insight Cohort

    A. Oliveira Franco, D. Teixeira-Dos-Santos, A. Noyce, S. Bandres-Ciga, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To compare late-onset and early-onset patients with Parkinson’s Disease (PD) in how they differ from their matched healthy controls (HC) regarding the presence of…
  • 2024 International Congress

    Association of insomnia with levodopa-related parameters in Parkinson’s disease

    L. Atabekyan, N. Nadryan, E. Balian, H. Karkourian, H. Hovakimyan, Z. Tavadyan, S. Khachatryan (Yerevan, Armenia)

    Objective: With this analysis we aimed to study the role of insomnia (both sleep onset and sleep maintenance insomnias) in Parkinson’s disease (PD) in relation…
  • « Previous Page
  • 1
  • …
  • 302
  • 303
  • 304
  • 305
  • 306
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley